Seminars in Oncology
Volume 31, Issue 2 , Pages 149-159, April 2004

Geriatric assessment and comorbidity

  • Arati V Rao

      Affiliations

    • Division of Geriatrics and the Center for the Study of Aging and Human Development, Durham, NC, USA
    • Geriatric Research, Education and Clinical Center (GRECC), Veterans Affairs Medical Center, Durham, NC, USA
    • Division of Medical Oncology and Transplantation, Duke University Medical Center, Durham, NC, USA
  • ,
  • Pearl H Seo

      Affiliations

    • Division of Geriatrics and the Center for the Study of Aging and Human Development, Durham, NC, USA
    • Geriatric Research, Education and Clinical Center (GRECC), Veterans Affairs Medical Center, Durham, NC, USA
  • ,
  • Harvey Jay Cohen

      Affiliations

    • Division of Geriatrics and the Center for the Study of Aging and Human Development, Durham, NC, USA
    • Geriatric Research, Education and Clinical Center (GRECC), Veterans Affairs Medical Center, Durham, NC, USA
    • Corresponding Author InformationAddress reprint requests to Harvey Jay Cohen, MD, Duke University Medical Center, Center for Aging, Box 3003, Durham, NC 27710, USA

Abstract 

Elderly persons, a rapidly growing population segment, have an increased incidence of cancer. The older cancer patient’s clinical evaluation and treatment is influenced by conditions such as disabilities, comorbidity, and functional status, along with tumor type and stage. These conditions and other geriatric syndromes can be identified by comprehensive geriatric assessment to guide therapy and affect prognosis and quality of life. Comprehensive geriatric assessment involves the medical, functional, affective, social, spiritual, and environmental assessments. The medical assessment, which includes a nutrition, vision, hearing, continence, gait and balance, and cognition evaluation, can provide additional information to performance status and comorbidity. Although there are many assessment domains using several instruments, comprehensive geriatric assessment can be focused and efficient, especially with a multidisciplinary team of nurses, social workers, pharmacists, and other personnel. Comorbid illnesses may have complex interactions, with the underlying cancer influencing cancer diagnosis, disease course, treatment-related side effects, and mortality. Many instruments are available for comorbidity measurement, and retrospective studies in elderly cancer cohorts have shown comorbidity to influence survival. However, the ultimate aim would be to use comorbidity and comprehensive geriatric assessments prospectively in the older cancer patient to help predict the suitability and success of treatment with various antineoplastic modalities.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(03)00664-X

doi:10.1053/j.seminoncol.2003.12.026

Seminars in Oncology
Volume 31, Issue 2 , Pages 149-159, April 2004